Invesco Biotechnology & Genome ETFPBE
PBE
0
Funds holding %
of 6,780 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
3% more funds holding
Funds holding: 99 [Q2] → 102 (+3) [Q3]
6.89% less ownership
Funds ownership: 41.52% [Q2] → 34.63% (-6.89%) [Q3]
14% less capital invested
Capital invested by funds: $107M [Q2] → $92.4M (-$14.4M) [Q3]
60% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 35
Research analyst outlook
We haven’t received any recent analyst ratings for PBE.
Financial journalist opinion
Neutral
Zacks Investment Research
1 week ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
3 weeks ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
2 months ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
2 months ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
4 months ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
6 months ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on 06/23/2005.
Neutral
Zacks Investment Research
6 months ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
Making its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE) provides investors broad exposure to the Health Care ETFs category of the market.
Positive
Seeking Alpha
8 months ago
PBE: Biotech Could Be Next Big Winner
Biotechnology and genomics sector has not performed well in recent years, making it an attractive investment opportunity. The Invesco Biotechnology & Genome ETF offers comprehensive exposure to the biotech sector with a diversified portfolio. PBE has performed better than some similar ETFs but worse than others, highlighting the importance of stock selection in this sector.
Neutral
Zacks Investment Research
8 months ago
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Charts implemented using Lightweight Charts™